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bstract
Adenosine is a neuromodulator acting through inhibitory A1 receptors (A1Rs) and facilitatory A2ARs. Since A2AR antagonists attenuate
emory deficits in aged animals and memory deficits might involve a decreased cholinergic function, we investigated how aging affects the
ensity and function of adenosine receptors in rat hippocampal cholinergic terminals. In young adult (2 months) rats, 64 and 36% of cholinergic
erminals (immunopositive for vesicular ACh transporters) possessed A1Rs and A2ARs, respectively. In aged (24 months) rats, the percentage
f cholinergic terminals with A1Rs was preserved, whereas that with A2ARs was larger (49%). In young adults adenosine only tonically
nhibited ACh release through A1Rs, whereas in aged rats there was a greater A1R-mediated inhibition and a simultaneous A2AR-mediated
acilitation of ACh release. Thus, the enhanced A2AR density and facilitation compensates for the greater tonic A1R modulation, preserving
he global adenosine modulation of ACh release in aged rats. Furthermore, since A2AR antagonists inhibit ACh release, the beneficial effects
f A2AR antagonists on memory in aged rats might not result from ACh release modulation.
2007 Elsevier Inc. All rights reserved.
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. Introduction
Adenosine is a neuromodulator that acts through activa-
ion of inhibitory A1 receptors (A1Rs) and facilitatory A2ARs,
hich are mainly located in synapses (Fredholm et al., 2005).Please cite this article in press as: Rodrigues, R.J. et al., Modification of a
of aged rats, Neurobiol Aging (2007), doi:10.1016/j.neurobiolaging.200
t was recently shown that A2AR antagonists recover memory
eficits in aged animals (Prediger et al., 2005) and in ani-
al models of Alzheimer’s disease (Dall’Igna et al., 2007).
 Disclosure: None of the authors has any actual or potential conflicts of
nterest including any financial, personal or other relationships with other
eople or organizations within 3 years of beginning the work submitted that
ould inappropriately influence (bias) our work. We also do not have con-
racts relating to this research through which ours or any other organization
ay stand to gain financially now or in the future. Our Institutions do not
ave a financial interest in this work.
∗ Corresponding author. Tel.: +351 239820190; fax: +351 239822776.
E-mail address: racunha@ci.uc.pt (R.A. Cunha).
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pon ageing, as well as upon chronic noxious brain condi-
ions, adenosine modulation is modified with increased levels
f adenosine, increased density and effects of A2ARs and a
ecrease of A1Rs (Cunha et al., 2001; Lopes et al., 1999;
eviewed in Cunha, 2005).
One hypothesis, still debatable (Bartus, 2000; Sarter and
runo, 2004), to explain age-related memory deterioration is
he cholinergic hypothesis, which is mainly based on the loss
f basal forebrain cholinergic neurons on aging and the effect
f anti-cholinergic drugs on learning and memory perfor-
ance (reviewed in Bartus, 2000). Cholinergic dysfunction
an affect memory by impacting on different cortical regions,
amely in the hippocampus, as made evident by the ability
f increasing hippocampal function by enhancing cholinergicdenosine modulation of acetylcholine release in the hippocampus
7.03.025
ransmission in individuals with memory deficits (Goekoop
t al., 2006; Gron et al., 2006). Since adenosine can modu-
ate the release of acetylcholine (ACh) in the hippocampus
f young adult rats through the activation of both inhibitory
 INNBA-6799; No. of Pages 5
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1 and facilitatory A2A receptors (Cunha et al., 1994), we
ow investigated if the beneficial effects afforded by A2A
eceptor antagonists in learning and memory abilities of aged
ats might be related to a modified adenosine receptor set-
ing and modulation of ACh release in the hippocampus
f aged rats. Thus, we tested how aging affects the den-
ity of adenosine receptors in cholinergic terminals and the
onic adenosine modulation of acetylcholine release in the rat
ippocampus.
. Methods
Male Wistar rats, either young adults (2 months, 140–
60 g) or aged (24 months, 780–940 g) were obtained
rom Harlan Ibe´rica (Barcelona, Spain). They were han-
led according to the EU guidelines for use of experimental
nimals (86/609/EEC), the rats being anesthetized under
alothane atmosphere before being sacrificed by decapita-
ion.
.1. Immunocytochemical analysis in nerve terminals
The double or triple labelling immunocytochemical
nalysis of hippocampal nerve terminals to quantify the local-
zation of A1 and A2A receptors in cholinergic terminals
as performed essentially as previously described (Rebola
t al., 2005). Nerve terminals from the rat hippocampus
ere purified through a discontinuous Percoll gradient (see
ebola et al., 2005) and placed onto coverslips previously
oated with poly-l-lysine, fixed with 4% paraformaldehyde
or 15 min and washed twice with PBS medium (140 mM
aCl, 3 mM KCl, 20 mM NaH2PO4, 15 mM KH2PO4, pH
.4). The synaptosomes were permeabilized in PBS with
.2% Triton X-100 for 10 min and then blocked for 1 h in
BS with 3% bovine serum albumin (BSA) and 5% nor-
al rat serum. The synaptosomes were then washed twice
ith PBS and incubated with goat anti-A2A receptor (1:500,
rom Santa Cruz Biotechnology-Europe, Freelab, Lisbon,
ortugal) and/or with rabbit anti-adenosine A1 receptor anti-
ody (1:400, from Affinity Bioreagents, Golden, USA),
ogether with guinea-pig anti-vesicular acetylcholine trans-
orter (vAChT) antibody (1:500, from Chemicon, Hofheim,
ermany) for 1 h at room temperature. The synaptosomes
ere then washed three times with PBS with 3% BSA and
ncubated for 1 h at room temperature with AlexaFluor-488
green) labelled donkey anti-goat IgG antibody (1:100), care-
ully washed with PBS and then incubated for 1 h at room
emperature with AlexaFluor-598 (red) labelled goat anti-
uinea-pig IgG (1:200) and AlexaFluor-350 (blue) labelled
oat anti-rabbit (1:100) (all from Invitrogen, Eugene, USA),
o avoid recognition of the goat anti-guinea-pig and goatPlease cite this article in press as: Rodrigues, R.J. et al., Modification of a
of aged rats, Neurobiol Aging (2007), doi:10.1016/j.neurobiolaging.200
nti-rabbit antibodies by the donkey anti-goat antibody. We
onfirmed that none of the secondary antibodies produced
ny signal in preparations to which the addition of the cor-
esponding primary antibody was omitted. In particular, we
2
t
t
t PRESS
of Aging xxx (2007) xxx–xxx
onfirmed that, in the absence of the goat anti-A2A receptor
ntibody, the addition to nerve terminals of the secondary
onkey anti-goat antibody followed by the subsequent addi-
ion of the secondary goat anti-guinea-pig and anti-rabbit
ntibodies did not yield any signal. Most importantly, we
onfirmed that the individual signals in double-labelled fields
re not enhanced over the signals under single-labelling
onditions. After washing and mounting on slides with Pro-
ong Antifade, the preparations were visualized in a Zeiss
xiovert 200 inverted fluorescence microscope equipped
ith a cooled CCD camera and analyzed with MetaFluor
.0 software. Each coverslip (three to four per experiment)
as analyzed by counting three different fields and in each
eld a minimum of 50 individualized elements. The val-
es are presented as the percentage of the total number of
holinergic terminals (i.e. immunopositive for the vesicu-
ar acetylcholine transporter) that were labelled with A1
nd/or A2A receptors and are displayed as mean ± S.E.M.
f n experiments (i.e. in preparation obtained from different
ats).
.2. Release of acetylcholine from hippocampal slices
The release of [3H]acetylcholine ([3H]ACh) from rat
ippocampal slices was performed as previously described
Cunha et al., 1994). Briefly, slices were loaded with
3H]choline (30Ci/ml, 0.3M) for 30 min, washed, placed
n 100-l Perspex chambers, and superfused with oxygenated
rebs solution containing 10M hemicholinium-3 at 30 ◦C
ith a flow rate of 0.6 ml/min. Slices were stimulated twice
S1 and S2) at 6 and 36 min with supra-maximal monopolar
quare-wave pulses with a duration of 3 ms and an amplitude
f 40 V, delivered with a frequency of 5 Hz for a period of
min (600 pulses), through platinum electrodes. Tested drugs
DPCPX, ZM241385 or adenosine deaminase) were added
o the superfusion medium 15 min before S2 and remained in
he bath up to the end of the experiment. The effect of drugs
as estimated by comparison of tritium release in control
hambers (no added drugs) and test chamber by quantifying
he ratio of the amount of tritium released in S2 (eventually
n the presence of tested drugs) and S1 (internal control). We
sed supra-maximal but selective concentrations of the A1
eceptor antagonist DPCPX (50 nM) and of the A2A recep-
or antagonist ZM241385 (50 nM), to determine the effect
f endogenous adenosine on each receptor (see Lopes et al.,
999; Rebola et al., 2005). To determine the effect of the
emoval of extracellular adenosine, we tested the effect of
U/ml of adenosine deaminase, as previously done (Cunha
t al., 2001). At the end of the release experiments, 5 ml
f scintillation cocktail (Scintran T) was added to a 500l
liquot of each eluent fraction and to 100l of the homoge-
ized slices (sonicated in 500l of 3 M perchloric acid anddenosine modulation of acetylcholine release in the hippocampus
7.03.025
% Triton X-100). The fractional release was expressed in
erms of the percentage of total radioactivity present in the
issue at the time of sample collection. The release of tri-
ium evoked by each period of electrical stimulation, i.e. the
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voked release (expressed as fractional release), was calcu-
ated by integration of the area of the peak upon subtraction
f the estimated basal tritium outflow from the total out-
ow due to electrical stimulation. The evoked release of
ritium under these conditions is Ca2+- and tetrodotoxin-
ensitive and is mostly constituted by [3H]ACh (Cunha et
l., 1994).
.3. Statistics
Values are mean ± S.E.M. of n experiments. The signif-Please cite this article in press as: Rodrigues, R.J. et al., Modification of a
of aged rats, Neurobiol Aging (2007), doi:10.1016/j.neurobiolaging.200
cance of the effects of tested drugs was calculated by the
aired Student’s t-test, and the effect of a drug between age
roups by the two-tailed Mann–Whitney U-test. P < 0.05 was
onsidered to represent a significant difference.
d
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c
o
ig. 1. Co-localization of adenosine A1 and A2A receptors in rat hippocampal chol
f A2A receptors (first panel from left), vesicular acetylcholine transporters (second
rom aged rats and the merged image (fourth from left) showing cholinergic termina
rrows), with only A2A receptors (yellow arrows) and with both A1 and A2A recepto
hotographed fields with at least three different fields per coverslip and three to fou
total number of 74 elements immunopositive for vAChTs, out of which 16 wer
eceptors and 28 were immunopositive for both A1 and A2A receptors. This experim
n = 7) aged (24 months, ‘24 m’) rats. (B) Displays the average percentage of rat h
AChTs) endowed with either A1 or A2A receptors in young adult (2 months, ‘2 m’,
ercentage of rat hippocampal cholinergic terminals endowed with only A1 or onl
ged rats (filled bars, n = 7). The data in the histograms are mean ± S.E.M. *P < 0.
eader is referred to the web version of the article.) PRESS
of Aging xxx (2007) xxx–xxx 3
. Results and discussion
We have previously shown that the release of acetylcholine
ACh) from hippocampal preparations is under the dual con-
rol of inhibitory A1 and facilitatory A2A receptors (A1Rs
nd A2ARs) (Cunha et al., 1994; Lopes et al., 1999). How-
ver, it is not clear if different cholinergic terminals in the
ippocampus are endowed with each of the receptors or
hether the two adenosine receptor subtypes are located in
he same cholinergic terminals. To answer this question, we
arried out double and triple immunocytochemical studies todenosine modulation of acetylcholine release in the hippocampus
7.03.025
etect A1Rs and A2ARs in hippocampal cholinergic nerve
erminals, identified as immunopositive for vesicular acetyl-
holine transporters (Fig. 1). In young adult rats (2 months
ld), 64.4 ± 3.1% of cholinergic terminals (immunopositive
inergic nerve terminals. (A) Shows the immunocytochemical identification
from left), A1 receptors (third from left) in rat hippocampal nerve terminals
ls without adenosine receptors (red arrows), with only A1 receptors (violet
rs (white arrows). These pictures are amplifications representative of larger
r coverslips per experiment. For instance, in this experiment we identified
e immunopositive only for A1 receptors, 7 immunopositive only for A2A
ent was repeated using different synaptosomal preparations from different
ippocampal cholinergic terminals (i.e. synaptosomes immunopositive for
open bars, n = 5) and aged rats (filled bars, n = 7). (C) Compares the average
y A2A or both A1 and A2A receptors in young adult (open bars, n = 5) and
05. (For interpretation of the references to colour in this figure legend, the
 INNBA-6799; No. of Pages 5
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This conclusion is of particular relevance to understand
the mechanisms operated by A2ARs to selectively enhance
mnemonic function in aged animals (Prediger et al., 2005).
Fig. 2. Comparison of the tonic modulation by endogenous adenosine of
[3H]acetylcholine ([3H]ACh) release from rat hippocampal slices of young
adult (2 months old, open bars) and aged rats (24 months old, filled bars).
The effect of the selective A1 receptor antagonist, DPCPX (50 nM), of the
selective A2A receptor antagonist, ZM241385 (50 nM) and of adenosineARTICLE
R.J. Rodrigues et al. / Neurob
or vesicular ACh transporters) were endowed with A1Rs
nd 35.9 ± 3.4% possessed A2ARs (n = 5). The two recep-
ors were co-located in 26.0 ± 2.6% of cholinergic terminals,
hereas 35.8 ± 2.5% were endowed only with A1Rs and vir-
ually none (4.0 ± 1.9%) of the cholinergic terminals were
ndowed with only A2ARs (n = 4). This shows that there is
n asymmetric distribution of adenosine receptors in the hip-
ocampus of young adult rats, such that 1/3 of cholinergic
erminals only has A1Rs, 1/3 has both A1Rs and A2ARs and
/3 apparently lacks adenosine receptors. This agrees with
he relative amplitude of the modulatory effects operated by
1Rs and A2ARs in the control of ACh release in hippocam-
al preparations from young adult rats (Cunha et al., 1994;
opes et al., 1999). There is a predominant A1R-mediated
nhibition of ACh release that causes a maximal inhibition of
ear 50% and a discrete A2AR-mediated facilitation (Cunha
t al., 1994; Jin and Fredholm, 1997; Lopes et al., 1999).
We then carried out the same double and triple immunocy-
ochemical labelling in aged rats (24 months old). We found
hat the percentage of cholinergic terminals with A1Rs was
reserved (53.3 ± 5.2%, n = 7, P > 0.05) compared to young
dult rats. In contrast, the percentage of cholinergic termi-
als with A2ARs was larger (49.0 ± 3.4%, n = 7, P < 0.05)
han in young adult rats. Finally, we found that the percent-
ge of cholinergic terminals simultaneously endowed with
1Rs and A2ARs (35.7 ± 1.3%, n = 5) was larger (P < 0.05)
han in young adult rats, and there was a lower proportion of
holinergic terminals endowed only with A1Rs (18.3 ± 2.9%,
= 5, P < 0.05) and a greater proportion of cholinergic termi-
als endowed only with A2ARs (13.4 ± 2.1%, n = 5, P < 0.05)
ompared to young adult rats. Thus, there is a re-distribution
f adenosine receptors in cholinergic terminals of aged rats
nd the major modification is a greater abundance of A2ARs
n cholinergic terminals. There is now a significant proportion
f cholinergic terminals with only A2ARs and a larger per-
entage of cholinergic terminals with both A1Rs and A2ARs.
n accordance with this greater abundance of A2ARs in hip-
ocampal cholinergic terminals of aged rats, the activation
f A2ARs causes a larger facilitation of ACh release in hip-
ocampal preparations from aged compared to young adult
ats (Lopes et al., 1999).
The density of the two receptors and the amplitude of
heir modulation effects upon activation with exogenously
dded agonists provide evidence of changes in the relative
mportance of the two receptors but does not tell us about
he intrinsic efficiency of these two receptors with oppo-
ite roles. In fact, this depends on the levels of endogenous
xtracellular adenosine tonically activating these two recep-
ors in cholinergic terminals. Previous studies have shown
hat the levels of endogenous extracellular adenosine are
arger in hippocampal preparations from aged compared to
oung adult rats (Cunha et al., 2001). When investigatingPlease cite this article in press as: Rodrigues, R.J. et al., Modification of a
of aged rats, Neurobiol Aging (2007), doi:10.1016/j.neurobiolaging.200
lutamatergic synaptic transmission, where there is also a
reater effect of A2AR agonists and a lower effect of A1R
gonists in aged rats, we found that the greater levels of
xtracellular adenosine cause a greater tonic A1R-mediated
d
i
e
m
b PRESS
of Aging xxx (2007) xxx–xxx
nhibition in aged rats (Sebastia˜o et al., 2000), while there is
o evidence of a tonic A2AR-mediated facilitation (Rebola
t al., 2003). Thus, we now compared the effect of endoge-
ous extracellular adenosine tonically modulating the release
f ACh in young adult and aged rats. The blockade of
1Rs, using the A1R-selective antagonist DPCPX (50 nM),
nhanced (17.2 ± 3.8%, n = 5) ACh release in young rats
see Cunha et al., 1994) and this tonic A1R-mediated inhibi-
ion was greater in aged rats (35.2 ± 4.0%, n = 6, P < 0.05).
here was also a more pronounced role of adenosine toni-
ally facilitating ACh release in aged rats since the blockade
f A2ARs with ZM241385 (50 nM) decreased ACh release
y 11.5 ± 1.3% (n = 7) in aged rats and was devoid of effects
−4.0 ± 1.4%, n = 6) in young adult rats. This indicates that
he lower levels of adenosine in young adults are only ton-
cally inhibiting ACh release through A1Rs, whereas the
reater levels of adenosine in aged rats (Cunha et al., 2001)
aused a greater A1R-mediated inhibition and a simultane-
us A2AR-mediated facilitation of ACh release. Accordingly,
emoving endogenous extracellular adenosine with 2 U/ml
denosine deaminase (converts adenosine into its centrally
nactive metabolite, inosine) caused a similar facilitation of
Ch release in young adult (15.3 ± 2.8%, n = 6) and aged
ats (19.3 ± 1.1%, n = 7, P > 0.05). These results indicate that
here is an enhanced A2AR density and facilitation of ACh
elease to compensate for the greater tonic A1R modulation
f ACh release, preserving the global adenosine modulation
f ACh release in aged rats (Fig. 2).denosine modulation of acetylcholine release in the hippocampus
7.03.025
eaminase (2 U/ml, which converts adenosine into its inactive metabolite
nosine) was estimated by following the evoked [3H]ACh release upon field-
lectrically stimulation (40 V, 3 ms, 5 Hz, 2 min) of the slices. Values are
eans ± S.E.M. of four to seven experiments. *P < 0.05% vs. 0%; **P < 0.05
etween the two age group.
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ne possible mechanism could be the control of ACh since
here is a hypofunction of the limbic cholinergic system upon
ging, which is considered a possible cause of cognitive dete-
ioration with aging (Bartus, 2000; Fischer et al., 1992; Sarter
nd Bruno, 2004). However, we now observed that there is
greater tonic A2AR-mediated facilitation of ACh release in
ippocampal slices from aged rats and that A2AR antagonists
ecrease ACh release in aged rats. Based on the hypothesis
f cholinergic hypofunction, this is precisely the opposite of
hat would be expected to understand the beneficial effect
f A2AR antagonists on memory performance in aged rats
i.e. drugs enhancing memory were expected to increase ACh
elease). Thus, the present results indicate that the benefits
fforded by A2AR antagonists on memory performance in
ged rats are likely not related to the control of the cholinergic
ystem. Further studies are required to explore if the benefi-
ial effects of A2AR antagonists on memory performance in
ged rats may instead involve the control of GABA release,
MDA receptors, astrocytic function or neuroinflammation
reviewed in Cunha, 2005; Fredholm et al., 2005).
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